Abbott (NYSE:ABT) today shared that it made its Lingo biowearable device available for purchase at Walmart stores.
Glaukos (NYSE:GKOS) announced today that the FDA approved its Epoxia incision-free alternative to corneal cross-linking ...
Abbott continues to get a boost in its Medical Devices business from its Diabetes unit's portfolio of continuous glucose ...
Investors have filed a lawsuit claiming Baxter (NYSE:BAX) violated federal securities laws as a result of issues with certain ...
Civica announced today that it plans to launch an affordable long-acting insulin in pre-filled pens starting in January 2026.
A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of California.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback